1. Home
  2. TBLA vs OGN Comparison

TBLA vs OGN Comparison

Compare TBLA & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$3.50

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.74

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBLA
OGN
Founded
2007
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
TBLA
OGN
Price
$3.50
$13.74
Analyst Decision
Strong Buy
Hold
Analyst Count
4
5
Target Price
$5.00
★ $11.40
AVG Volume (30 Days)
1.8M
★ 2.5M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
★ 0.60%
EPS Growth
★ 1400.00
N/A
EPS
★ 220.00
0.95
Revenue
$1,912,040,000.00
★ $6,216,000,000.00
Revenue This Year
$7.63
$0.45
Revenue Next Year
$5.25
$1.67
P/E Ratio
★ $0.02
$14.44
Revenue Growth
★ 8.26
N/A
52 Week Low
$2.84
$5.69
52 Week High
$5.71
$13.79

Technical Indicators

Market Signals
Indicator
TBLA
OGN
Relative Strength Index (RSI) 34.68 59.92
Support Level $2.97 $13.46
Resistance Level $3.94 $13.79
Average True Range (ATR) 0.12 0.04
MACD -0.01 -0.00
Stochastic Oscillator 20.87 70.00

Price Performance

Historical Comparison
TBLA
OGN

About TBLA Taboola.com Ltd.

Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: